Aerie Pharmaceuticals Profile

53.85
USD 1.05  1.99%
100%

Selected Aerie Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Aerie Pharmaceuticals Against Markets

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Aerie Pharmaceuticals, Inc. was founded in 2005 and is based in Irvine, California. Aerie Pharmaceuticals operates under Drug Manufacturers - Major classification in USA and traded on NASDAQ General Markets exchange. It employs 95 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAerie Pharmaceuticals Inc
Chairman and CEOVicente AnidoAll Leadership
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationNORTH CAROLINA, U.S.A
Business Address2030 Main Street
ExchangeNASDAQ General Markets
CIK Number01337553.0
CUSIP00771V108
SectorHealthcare
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.aeriepharma.com
Contact Number949 526 8700
CurrencyUSD - US Dollar

Recommendations

Aerie Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
56.5Buy10Odds
Aerie Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Aerie Pharmaceuticals Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Aerie Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.66March 7, 2017
Aerie Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Aerie Pharmaceuticals Corporate Directors
Julie McHugh Independent Director, MBA
Benjamin McGraw Independent Director, Ph.D
Anand Mehra Director, Ph.D